EP2970473
Samsetning á DR5 -örva og AND-PD-1 mótlyfi og aðferðir við notkun
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.3.2014EP published:
16.8.2017EP application number:
14717294.4
EP translation filed:
30.10.2017Grant published:
15.11.2017EPO information:
European Patent Register
Max expiry date:
11.3.2034Expiry date:
11.3.2020
Title:
COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE
Timeline
Today
12.3.2014EP application
16.8.2017EP Publication
30.10.2017Translation submitted
15.11.2017Registration published
11.3.2020Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
Inventor
Name:
BARNHART, BryanAddress:
Princeton, NJ, US
Name:
JURE-KUNKEL, Maria, N.Address:
Princeton, NJ, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201361783184 PDate:
14.3.2013Country:
US
Classification
Categories:
C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 8.2.2018
Expires: 11.3.2019
Payer: Árnason Faktor
Number: 6
Paid: 7.2.2019
Expires: 11.3.2020
Payer: Árnason Faktor